SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042707
Filing Date
2021-08-09
Accepted
2021-08-09 16:45:55
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ccxi-10q_20210630.htm   iXBRL 10-Q 2567162
2 EX-31.1 ccxi-ex311_9.htm EX-31.1 9414
3 EX-31.2 ccxi-ex312_7.htm EX-31.2 9362
4 EX-32.1 ccxi-ex321_8.htm EX-32.1 6167
5 EX-32.2 ccxi-ex322_6.htm EX-32.2 6275
  Complete submission text file 0001564590-21-042707.txt   9419024

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20210630.xsd EX-101.SCH 54462
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20210630_cal.xml EX-101.CAL 57669
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20210630_def.xml EX-101.DEF 135408
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20210630_lab.xml EX-101.LAB 415113
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20210630_pre.xml EX-101.PRE 305659
11 EXTRACTED XBRL INSTANCE DOCUMENT ccxi-10q_20210630_htm.xml XML 2143064
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 211157148
SIC: 2834 Pharmaceutical Preparations